We implement minimally invasive non-surgical regenerative therapy for osteoarthritis and musculoskeletal Injuries
In the rapidly evolving field of regenerative medicine, Auckland Regenerative Clinic (ARC) stands at the forefront, offering cutting-edge, non-surgical solutions for osteoarthritis and musculoskeletal injuries. Led by Dr. Hassan Mubark, a senior rheumatologist with over 30 years of experience, ARC is redefining patient care through innovative treatments like stem cell therapy, platelet-rich plasma (PRP), and advanced imaging-guided interventions.
Recognized for its commitment to ethical medical practices, sustainability, and groundbreaking research, ARC has been named a Business Excellence Awards 2025 honoree. With aspirations to expand its reach, drive research in gene therapy for osteoarthritis, and establish itself as a global leader in regenerative healthcare, ARC is shaping the future of non-invasive medical solutions.
In this exclusive interview, we dive into the clinic’s mission, innovations, and future aspirations with Dr. Hassan Mubark, uncovering how ARC is revolutionizing regenerative medicine.
Can you provide a brief overview of Auckland Regenerative Clinic, its mission, and the core principles driving its operations?
Auckland Regenerative Clinic (ARC) is a private medical facility specializing in regenerative medicine treatments, including stem cell therapy, platelet-rich plasma (PRP), and viscous hyaluronic injections (GEL). Their mission is to provide non-surgical alternatives for individuals experiencing joint pain, stiffness, and other musculoskeletal issues, aiming to enhance patients’ quality of life without invasive procedures. The clinic operates under New Zealand’s medico-ethical guidelines, emphasizing patient choice and adherence to ethical standards. Dr. Hassan Mubark, a senior rheumatologist with over 30 years of experience, leads the clinic. He has been recognized for his contributions to regenerative medicine, including being named a semi-finalist for the 2025 Kiwibank New Zealander of the Year Awards.
Can you elaborate on the initiatives and practices you implement to align with ARC principles?
We are committed to delivering patient-centered care by tailoring treatment plans to individual needs while providing transparent and comprehensive information to ensure informed decision-making. Our approach integrates cutting-edge regenerative technologies, including stem cell therapy and platelet-rich plasma (PRP) treatments, supported by advanced diagnostic tools to enhance precision and effectiveness.
Ethical integrity is at the core of our practice, reflected in our dedication to patient safety, regulatory compliance, and open communication. We actively contribute to the field of regenerative medicine through continuous professional development, offering staff ongoing training and engaging in clinical research to refine and advance treatment methodologies.
Sustainability is another key principle in our operations. We implement environmentally responsible practices by minimizing medical waste and adopting eco-friendly solutions wherever possible. Additionally, we emphasize long-term patient well-being by providing post-treatment support, rehabilitation guidance, and preventative strategies to promote sustained health improvements. Through these initiatives, ARC remains committed to ethical, innovative, and sustainable healthcare solutions that enhance patients’ quality of life.
How do your offerings stand out from competitors in the industry?
Our offerings distinguish us from competitors through a unique blend of advanced regenerative technologies, personalized patient care, and an unwavering commitment to excellence. We specialize in innovative treatments such as platelet-rich plasma (PRP) therapy and stem cell applications, utilizing precision diagnostics to ensure targeted and effective outcomes.
What sets us apart is our emphasis on patient education and empowerment. We provide transparent, in-depth information about available treatment options, enabling individuals to make informed decisions about their health. Unlike many providers, we integrate a holistic approach that not only focuses on symptom relief but also promotes long-term musculoskeletal health and overall well-being.
Our commitment to evidence-based practices, strict adherence to ethical standards, and active participation in ongoing clinical research further reinforce our reputation for high-quality care. By combining cutting-edge medical advancements with a patient-first philosophy, ARC continues to lead the way in regenerative medicine, offering innovative, ethical, and effective solutions for those seeking non-surgical alternatives.
What innovative strategies or technologies have you introduced to maintain excellence in your field?
We uphold excellence by integrating innovative strategies and advanced technologies in regenerative medicine. Our treatments, including platelet-rich plasma (PRP) therapy and stem cell applications, harness the body’s natural healing processes to promote tissue repair and recovery.
To enhance precision and effectiveness, we utilize cutting-edge imaging technologies such as ultrasound-guided injections, ensuring targeted delivery and improved patient outcomes. Our data-driven approach allows us to personalize treatment plans based on each patient’s unique condition, optimizing recovery and long-term benefits.
We also collaborate with leading research institutions to stay at the forefront of regenerative medicine, continuously refining our protocols to incorporate the latest scientific advancements. This commitment to ongoing research ensures that we provide evidence-based, state-of-the-art care.
Additionally, we have embraced telemedicine to improve accessibility and patient convenience, offering virtual consultations that allow for continuous care and follow-up support. By integrating these innovations, ARC remains a leader in regenerative medicine, delivering cutting-edge, patient-centered solutions with a focus on long-term health and well-being.
What is the Auckland Regenerative goals and aspirations for the next five years?
Auckland Regenerative Clinic (ARC) is committed to advancing regenerative medicine and improving patient outcomes through innovation, accessibility, and sustainability. Over the next five years, our key goals and aspirations include:
Expanding Access to Care
- We aim to broaden the availability of advanced regenerative therapies by establishing new locations and forming strategic partnerships, ensuring more patients can benefit from cutting-edge treatments.
Advancing Research and Innovation
- By conducting clinical trials and collaborating with research institutions, we strive to develop and refine effective treatment protocols, maintaining our position at the forefront of regenerative medicine.
Enhancing Patient Outcomes
- We will continuously integrate the latest technologies and treatment advancements to improve success rates, delivering personalized, high-quality care tailored to each patient’s needs.
Fostering Sustainability
- Sustainability remains a core focus, with initiatives aimed at reducing medical waste, implementing eco-friendly practices, and aligning our operations with environmental and social responsibility.
Building Global Recognition
- ARC aspires to establish itself as a global leader in regenerative medicine through collaborations with international experts, participation in medical conferences, and contributions to scientific research.
Exploring Gene Therapy for Osteoarthritis
- We are dedicated to investigating gene therapy as a revolutionary treatment for osteoarthritis, targeting disease modification at a molecular level to promote cartilage repair and prevent degeneration.
These goals reflect ARC’s dedication to shaping the future of regenerative medicine, improving healthcare accessibility, and enhancing the quality of life for our patients.
How does being featured in the Business Excellence Awards 2025 align with your company’s values and ambitions?
Being featured in the Business Excellence Awards 2025 aligns seamlessly with Auckland Regenerative Clinic’s (ARC) values and long-term ambitions. This recognition underscores our dedication to innovation, ethical medical practices, and delivering outstanding patient-centered care. It affirms our commitment to advancing regenerative medicine by integrating the latest research, precision diagnostics, and non-surgical treatment solutions.
The award also strengthens our credibility within the healthcare industry, reinforcing patient trust and professional integrity. It highlights our focus on continuous improvement, collaborative research, and sustainable healthcare practices.
Moreover, this acknowledgment motivates us to push the boundaries of regenerative medicine, expanding access to advanced treatments while maintaining the highest standards of excellence. By being recognized for business excellence, ARC moves closer to its vision of becoming a global leader in regenerative healthcare, shaping the future of non-invasive medical solutions.
Can you share insights into the leadership team and their role in steering ARC toward its goals?
Our leadership team comprises experienced professionals with expertise in regenerative medicine, innovation, and patient care. They play a crucial role in setting strategic direction, fostering a culture of excellence, driving research and development, and ensuring the delivery of cutting-edge treatments to achieve ARC’s goals.
“We uphold excellence by integrating innovative strategies and advanced technologies in regenerative medicine.”
“We specialize in innovative treatments such as platelet-rich plasma (PRP) therapy and stem cell applications”
“ARC remains committed to ethical, innovative, and sustainable healthcare solutions that enhance patients' quality of life.”
Company Name : Auckland Regenerative Clinic
Website : https://regenerative.nz/
Management Team
Dr. Hassan Mubark | CEO
